Comparative Analysis of Salivary and Serum Inflammatory Mediator Profiles in Patients With Rheumatoid Arthritis and Periodontitis
Mediators of Inflammation · 2025-01 · 2025 (1)
DOI: 10.1155/mi/7739833 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Mediators of Inflammation, online erschienen am 20.03.2025. Verfasst von Carina Fei und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dental Medicine, Division of Pediatric Dentistry, Karolinska Institutet, Huddinge, Sweden. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Periodontitis, Saliva, Inflammation Mediators. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stockholm läns landsting, Reumatikerförbundet, Vetenskapsrådet.
Abstract (Originalsprache)
Background
Periodontitis (PD) and rheumatoid arthritis (RA) are chronic inflammatory conditions, characterized by dysregulated immune response and excessive production of inflammatory mediators. The oral disease PD is triggered by periodontal pathogens, leading to the destruction of tissues surrounding the teeth, whereas RA is a systemic autoimmune disease primarily affecting the joints. The objective of this study was to investigate the prevalence of PD and map the profile of salivary and serum inflammatory mediators of patients with RA, with respect to periodontal severity (PD stage II and PD stage III/IV).
Methods
For this cross‐sectional cohort study, 62 patients diagnosed with RA were recruited. All participants underwent a full‐mouth dental examination. Levels of various inflammatory mediators, including tumor necrosis factor (TNF) superfamily proteins, interferon (IFN) family proteins, regulatory T cell (Treg) cytokines, and matrix metalloproteinases were determined in saliva and serum samples from each participant using a human inflammation multiplex immunoassay panel.
Results
In the current RA cohort, all participants were diagnosed with PD, of which 35.5% were classified as PD stage II and 64.5% as PD stages III/IV. Inflammatory mediator levels were significantly higher in both saliva and serum samples from patients with RA and PD stages III/IV, compared to those with RA and stage II within the same cohort. These included higher serum levels of sCD30, IL‐10, IL‐19, osteopontin and elevated salivary levels of BAFF/TNFSF13B and IFN‐ α 2. Additionally, APRIL/TNFSF13 levels were increased in both saliva and serum.
Conclusions
Among the studied patients with RA, the majority exhibited severe PD (stage III/IV), underscoring the importance of periodontal prophylaxis and treatment for this group of patients. Higher levels of inflammatory mediators were observed in both saliva and serum in those with PD stages III/IV, suggesting a potential link between the severity of PD and systemic inflammation in RA. Further research is needed to explore the clinical implications of these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dental Medicine, Division of Pediatric Dentistry, Karolinska Institutet, Huddinge, Sweden.
- Center for Rheumatology, Academic Specialist Centre, Stockholm, Sweden.
- Rheumatology Unit, Karolinska University Hospital, Huddinge, Sweden.
- Department of Gene Technology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden.
- Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden.
- Center of Pediatric Oral Health Research, Stockholm, Sweden.
ORCID-Profile: Carina Fei, Kaja Eriksson, Luis Fernando Delgado Zambrano, Mehrad Mohammadi, Georgios Tsilingaridis, Rikard Holmdahl, Leif Jansson, Tülay Yucel-Lindberg
Förderung
- Stockholm läns landsting
- Reumatikerförbundet
- Vetenskapsrådet
Zitieren
APA
Fei, C., Eriksson, K., Fei, G., Delgado Zambrano, L. F., Syed, S., Lindström, C., Ericson, M., Mohammadi, M., Tsilingaridis, G., Guenifi, A., Holmdahl, R., Jansson, L., & Yucel-Lindberg, T. (2025). Comparative Analysis of Salivary and Serum Inflammatory Mediator Profiles in Patients With Rheumatoid Arthritis and Periodontitis. Mediators of Inflammation, 2025(1). https://doi.org/10.1155/mi/7739833
Vancouver
Fei C, Eriksson K, Fei G, Delgado Zambrano LF, Syed S, Lindström C, et al. Comparative Analysis of Salivary and Serum Inflammatory Mediator Profiles in Patients With Rheumatoid Arthritis and Periodontitis. Mediators of Inflammation. 2025;2025(1). doi:10.1155/mi/7739833
BibTeX
@article{Fei2025,
author = {Fei, Carina and Eriksson, Kaja and Fei, Guozhong and Delgado Zambrano, Luis Fernando and Syed, Shigufta and Lindström, Caroline and Ericson, Martina and Mohammadi, Mehrad and Tsilingaridis, Georgios and Guenifi, Amel and Holmdahl, Rikard and Jansson, Leif and Yucel-Lindberg, Tülay},
title = {Comparative Analysis of Salivary and Serum Inflammatory Mediator Profiles in Patients With Rheumatoid Arthritis and Periodontitis},
journal = {Mediators of Inflammation},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/mi/7739833}
}
EUVIMED